Completed PHASE4 INTERVENTIONAL 1-arm NCT01127269

Safety and Effectiveness Study of Insulin Glargine (LANTUS) Initiation and Titration in Patients With Type 2 Diabetes (AFICIONADO)

Practical Implementation of ADA/EASD Consensus Algorithm in Patients With Type 2 Diabetes: Timely Insulin Initiation and Titration

Sponsor: Sanofi

Conditions Diabetes Mellitus, Type 2

Interventions INSULIN GLARGINE

Updated 6 times since 2017 Last updated: Jul 16, 2014 Started: May 31, 2010 Primary completion: Jun 30, 2013 Completion: Jun 30, 2013

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE4 clinical study on Diabetes Mellitus, Type 2, this trial is completed. The trial is conducted by Sanofi and has accumulated 6 data snapshots since 2010. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

6 versions recorded

Jan 2026 — Present [monthly]

Completed PHASE4
Sep 2024 — Present [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Jan 2021 — Jul 2024 [monthly]

Completed PHASE4
Jun 2018 — Jan 2021 [monthly]

Completed PHASE4

▶ Show 1 earlier version

Jan 2017 — Jun 2018 [monthly]

Completed PHASE4

First recorded

May 2010

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Sanofi

Data source: Sanofi

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

C.a.b.a., Argentina , Caba, Argentina , Capital Federal, Argentina , Mar del Plata, Argentina , Moreno -Pcia. de Bs. As.-, Argentina , Morón, Argentina , Paraná, Argentina , Salta, Argentina , Sarandí, Argentina , Tandil, Argentina and 1 more location